INJ: $10 Billion in Real Estate Collateral Set to Migrate + 3 Spot ETF Staking Applications! Injective Charges Toward $9—Can It Be Traded as Though Approval Is Already Granted?

The clear standout today, backed by major filings and industry partnerships! Injective (INJ) surged 12.96% to $9.005 (peaking at $9.19 intraday), with 24-hour trading volume jumping to $290 million!
Here are the three major developments:
1. ETF applications moving forward: 21Shares amended its spot INJ ETF application (proposing direct holdings and staking, Nasdaq ticker TINJ), while Canary and REX-Osprey also filed staking-enabled applications;
2. $10 billion asset migration plan: Canadian-listed Pentiv (formerly Pineapple) announced plans to migrate a real estate mortgage portfolio worth approximately $10 billion onto the Injective blockchain;
3. Token supply and deflation: IIP-617 continues to reduce supply, while perpetual open interest has surged by more than $35 million in recent days.
Bottom line: Take note: The ETFs have not yet been approved, and the $10 billion in collateral has not yet been fully migrated! The market is currently trading on expectations ahead of time. $8.000 is the key round-number support level. Until official approval is granted, don’t treat this as a confirmed, realized catalyst and pile on leverage at elevated prices!
#İNJ #Injective #RWA #加密ETF #DeFi
$INJ